Screener Summaries Updates Institutions Sign In More Updates › Other Events › RADX Other Events · Jul 6, 2026
On July 3, 2026, Radiopharm Theranostics Limited announced it received a $5.9 million R&D tax incentive RADX Radiopharm Theranostics Ltd
On July 3, 2026, Radiopharm Theranostics Limited announced it received a $5.9 million R&D tax incentive. The company operates in the biotechnology industry, focusing on the development of radiopharmaceuticals for cancer diagnosis and therapy.
More from Radiopharm Theranostics Ltd All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
